Literature DB >> 12539586

A modified method for preparation of adriamycin carried by magnetic albumin microspheres.

J Ma1, D Chen, Y Tian.   

Abstract

The targeting of antineoplastic agents to restricted anatomic sites and specific target cells have been challenged clinicians all the time in cancer chemotherapy, which resulted in recent efforts to focus the effects of existing antitumor agents and treatments on tumor cells and spare their effects on normal cells. The drug-carrier complex, adriamycin carried by magnetic albumin microspheres (ADM-MAM) was prepared by using our discovered new and modified method. The physical feature of the prepared drug-carrier microspheres was much better than by the traditional method in comparison. The successful preparation of the drug-carrier complex, ADM-MAM, is one of the key steps for our later further researches in the targeted chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12539586     DOI: 10.1007/BF02886439

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

Review 1.  Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.

Authors:  K J Widder; A E Senyei; D F Ranney
Journal:  Adv Pharmacol Chemother       Date:  1979

2.  New magnetic drug carrier.

Authors:  A Ibrahim; P Couvreur; M Roland; P Speiser
Journal:  J Pharm Pharmacol       Date:  1983-01       Impact factor: 3.765

3.  Magnetic microspheres: synthesis of a novel parenteral drug carrier.

Authors:  K Widder; G Flouret; A Senyei
Journal:  J Pharm Sci       Date:  1979-01       Impact factor: 3.534

4.  Magnetic protein A microspheres: a rapid method for cell separation.

Authors:  K J Widder; A E Senyei; H Ovadia; P Y Paterson
Journal:  Clin Immunol Immunopathol       Date:  1979-11

5.  In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.

Authors:  K J Widder; A E Senyei; D F Ranney
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

6.  Sustained-release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog.

Authors:  T Kato; R Nemoto; H Mori; I Kumagai
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

7.  Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.

Authors:  K J Widder; R M Morris; G Poore; D P Howard; A E Senyei
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.